Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_1
1
20%
Ph early_phase_1
3
60%

Phase Distribution

4

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
3(60.0%)
Phase 1Safety & dosage
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Other(5)

Detailed Status

unknown5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
N/A
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 13 (60.0%)
Phase 11 (20.0%)
N/A1 (20.0%)

Trials by Status

unknown5100%

Recent Activity

0 active trials
Showing 5 of 5
unknownearly_phase_1

CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia

NCT04626765
unknownearly_phase_1

Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation

NCT04626726
unknownearly_phase_1

CAR-T Cells in Treating Patients With Relapsed or Refractory NHL

NCT04626739
unknownnot_applicable

Safety and Efficacy Study of CD22 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT04546906
unknownphase_1

CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies

NCT02794961

Clinical Trials (5)

Showing 5 of 5 trials
NCT04626765Early Phase 1

CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia

Unknown
NCT04626726Early Phase 1

Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation

Unknown
NCT04626739Early Phase 1

CAR-T Cells in Treating Patients With Relapsed or Refractory NHL

Unknown
NCT04546906Not Applicable

Safety and Efficacy Study of CD22 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia

Unknown
NCT02794961Phase 1

CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5